INOVIO , and Akeso, Inc. (9926.HK) ("Akeso") today announced that they have entered into a clinical trial collaboration and supply agreement to evaluate INO-5412, INOVIO's DNA immunotherapy candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results